Every trade that managers of Noveris Health Sciences Inc. disclose to SEDI is tracked on this page. Over the twelve months to 24 October 2026, 5 filings were filed, from 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Compared with its exchange (2,472 companies, median 13 filings), a count of 5 filings is below the norm.
Insider buying of Noveris Health Sciences Inc. has been absent for the past year. Typically, a trade is published a median of 30 days after it takes place. That lag is the time during which only the insider knows about the trade.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
5 of 5 declarations
Noveris Health Sciences Inc. is a company focused on the health sciences sector. It is listed on the Toronto Stock Exchange under the symbol XTSE.